Pulmonary Endarterectomy Improves Dyspnea by the Relief of Dead Space Ventilation

Size: px
Start display at page:

Download "Pulmonary Endarterectomy Improves Dyspnea by the Relief of Dead Space Ventilation"

Transcription

1 ORIGINAL ARTICLES: GENERAL THORACIC GENERAL THORACIC SURGERY: The Annals of Thoracic Surgery CME Program is located online at To take the CME activity related to this article, you must have either an STS member or an individual non-member subscription to the journal. GENERAL THORACIC Pulmonary Endarterectomy Improves Dyspnea by the Relief of Dead Space Ventilation Mart N. van der Plas, MS, Herre J. Reesink, MD, PhD, Carel M. Roos, MD, Reindert P. van Steenwijk, MD, Jaap J. Kloek, MD, and Paul Bresser, MD, PhD Departments of Respiratory Medicine and Cardiothoracic Surgery, Academic Medical Centre, University of Amsterdam; and Department of Respiratory Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands Background. In chronic thromboembolic pulmonary hypertension (CTEPH), dyspnea is considered to be related to increased dead space ventilation caused by vascular obstruction. Pulmonary endarterectomy releases the thromboembolic obstruction, thereby improving regional pulmonary blood flow. We hypothesized that pulmonary endarterectomy reduces dead space ventilation and that this reduction contributes to attenuation of dyspnea symptoms. Methods. In this follow-up study we assessed dead space ventilation, hemodynamic severity of disease, and symptomatic dyspnea in 54 consecutive CTEPH patients, before and 1 year after pulmonary endarterectomy. Dead space ventilation was calculated using the Bohr-Enghoff equation. Dyspnea was assessed by Borg scores and the New York Heart Association functional classification. Results. Preoperatively, dead space ventilation was increased ( ) and correlated with severity of disease (mean pulmonary artery pressure: r 0.49, p < 0.001; total pulmonary resistance: r 0.53, p < 0.001), and resting (r 0.35, p < 0.05) and post-exercise Borg dyspnea scores (r 0.44, p < 0.01). Postoperatively, dead space ventilation ( , p < 0.001) and dyspnea symptoms decreased significantly. Changes in symptomatic dyspnea were independently associated with changes in pulmonary hemodynamics and absolute dead space. Conclusions. Dead space ventilation in CTEPH is increased and correlates significantly with hemodynamic severity of disease and dyspnea symptoms. Pulmonary endarterectomy decreases dead space ventilation. The induced change in dead space upon surgical removal of chronic thromboembolism contributes to the postoperative recovery of symptomatic dyspnea. (Ann Thorac Surg 2010;89:347 52) 2010 by The Society of Thoracic Surgeons Accepted for publication Aug 3, Address correspondence to Dr van der Plas, Academic Medical Centre, University of Amsterdam, Department of Respiratory Medicine, F5-260, PO Box 22700, Amsterdam, 1100 DE, the Netherlands; m.n.vanderplas@amc.uva.nl. Chronic thromboembolic pulmonary hypertension (CTEPH) results from incomplete resolution of the vascular obstruction associated with pulmonary embolism [1, 2]. Dyspnea is the common presenting symptom in patients with CTEPH [3, 4] and is associated with decreased exercise performance, functional status, and quality of life [5]. In CTEPH, dyspnea is partly considered related to ventilation-perfusion mismatching caused by the thromboembolic obstruction of the pulmonary vascular bed [6]. Dead space ventilation increases as blood flow fails to perfuse the ventilated lung. To compensate for this increase in dead space ventilation, the patient s ventilatory requirement increases, leading to a sensation of dyspnea. So far, however, evidence that dead space ventilation is indeed related to the sensation of dyspnea in CTEPH patients is lacking. Pulmonary endarterectomy (PEA) represents the therapy of choice for CTEPH patients with surgically accessible thrombi [1, 3, 7]. PEA has been found to improve and often normalizes pulmonary hemodynamics and New York Heart Association (NYHA) functional status [7 15]. PEA was also reported to cause improvement in pulmonary perfusion [16] and ventilation-perfusion relationships [17]. Surprisingly, however, most likely due to the low number of patients studied, a significant decrease in dead space ventilation after PEA has not been demonstrated [17]. We hypothesized that PEA leads to reduced dead space ventilation in CTEPH patients and that a decrease in dead space ventilation is associated with improvement of dyspnea symptoms. Therefore, we studied the effect of PEA on dead space ventilation in a larger cohort of consecutive CTEPH patients, and assessed whether the changes in dead space ventilation after PEA were related to the reported changes in symptomatic dyspnea. Material and Methods The research protocol for this study was approved by the local Institutional Review Board and the study was con by The Society of Thoracic Surgeons /10/$36.00 Published by Elsevier Inc doi: /j.athoracsur

2 GENERAL THORACIC 348 VAN DER PLAS ET AL Ann Thorac Surg DEAD SPACE AND DYSPNEA AFTER PEA 2010;89: ducted in accordance with the principles of the Declaration of Helsinki. Patients Patients with operable CTEPH, referred to the Academic Medical Centre of the University of Amsterdam, were considered eligible for this study. Diagnosis of CTEPH was established on the basis of previously reported procedures [18]. Diagnosis and cardiopulmonary hemodynamics were determined by pulmonary angiography and right heart catheterization. Pulmonary hypertension was defined as mean pulmonary artery pressure (mpap) exceeding 25 mm Hg at rest or exceeding 30 mm Hg during a standardized exercise test on a cycle ergometer [19]. All patients received oral anticoagulation therapy for at least 3 months before referral to our hospital. Study Design The follow-up design included assessments performed before and after intervention. Measurement of dead space ventilation and assessment of dyspnea was routine in all patients during the preoperative workup. Postoperative hemodynamics were determined on the first or second day after PEA, before removal of the Swan-Ganz catheter. Dead space ventilation and dyspnea scores were reassessed 1 year after PEA. Dead Space Ventilation Bohr s dead space ventilation (V D /V T ) was measured with the patient supine. Exhaled air was collected using a two-way valve and Douglas bag during 5 minutes of tidal breathing. After 2 minutes, a blood sample was taken from the radial artery. The arterial blood samples and expiratory gases were analyzed (ABL 700, Radiometer, Copenhagen, Denmark), and expiratory volume was measured via a dry gas meter (Mijnhardt, the Netherlands). Absolute dead space (V D ) in milliliters and dead space ventilation (V D /V T ) were calculated using the Bohr-Enghoff equation [20]. AV D /V T of 0.30 or less is considered normal [21]. Because Bohr dead space ventilation is known to be sensitive to shunting, the effect of shunting on the calculated Bohr-Enghoff V D /V T was assessed using the equation for shunt independent V D /V T according to Kuwabara and Duncalf [22]. Dyspnea Assessment Dyspnea was assessed using two different methods: the NYHA functional classification and the Borg score. NYHA functional class is a doctor-reported dyspnea scoring system that quantifies a patient s level of exercise intolerance, expressing the patients (dis)ability to perform everyday activities [23]. Each patient was classified by an independent physician according to the NYHA classification of the World Health Organization before enrolment in the study and at 1 year after PEA. The Borg score is a patient-reported quantitative scaling method of the symptomatic dyspnea [24]. Patients rate their own dyspnea on a scale from 0 (no dyspnea) to 10 (absolutely breathlessness). The Borg score is a momentary measurement, which can change rapidly over time and with activities, allowing the assessment of the effect of exercise on the dyspnea. We assessed the Borg score before and immediately after a 6-minute walk test (6-MWT) that was performed according to the guidelines of the American Thoracic Society (ATS), as previously described [14, 25]. The 6-MWT was introduced in a later stage of the program, so it was performed in 38 consecutive patients only. Surgical Procedure PEA was performed according to the protocol of the University of California, San Diego [3, 26]. PEA is performed through a median sternotomy. After initiation of cardiopulmonary bypass, during deep hypothermia (20 C), the right pulmonary artery is incised where it passes the aorta to the division of the lower lobe arteries. On the left, the incision extends from the main pulmonary artery to the origin of the left upper lobe branch. The organized thromboembolic material is fibrotic and adherent to the vessel wall. An endarterectomy plane is established between the intima and the fibrotic thromboembolic material. The obstructing material is then grasped with a forceps, and distal, circumferential dissection is performed with an aspirating dissector. Circulatory arrest is mandatory to ensure optimal visibility in the presence of usually copious retrograde blood flow from a hypertrophied bronchial circulation. The circulatory arrest period is limited to 20 minutes, with restoration of flow between each arrest. Statistical Analysis Results are expressed as mean standard deviation. All analyses were performed with the SPSS 13.0 software (SPSS, Chicago, IL). Borg score and NYHA functional class were considered as numeric outcome values in a stepwise multivariate linear regression analysis. The Pearson correlation test was used to assess correlations between dead space ventilation, Borg score, NYHA, and the hemodynamic and ventilatory variables and was tested for two-sided significance. Multivariate linear regression analysis of all individual parameters that correlated significantly with the Borg score or the NYHA functional class was performed to calculate the predictive value of different parameters in relation to the Borg score and the NYHA. A paired t test was used to analyze the effect of PEA. A value of p 0.05 was considered statistically significant. Results Patient Characteristics The study included 54 consecutive patients (21 men, 33 women) who were a mean age of (range, years). Most of the 48 patients with pulmonary arterial hypertension at rest had moderate to severe pulmonary hypertension, with a median mpap of 48 mm Hg (range, mm Hg) and a median total pulmonary resistance (TPR) of 800 (dynes s cm 5 (range, 346 to 1875 dynes s cm 5 ). Six additional patients with exercise-

3 Ann Thorac Surg VAN DER PLAS ET AL 2010;89: DEAD SPACE AND DYSPNEA AFTER PEA Table 1. Effect of Pulmonary Endarterectomy (n 47) Variable Before PEA Mean SD After PEA Mean SD p Value mpap, mmhg TPR, dynes s cm V D /V T V D, L V D,alv /V T V D,anat /V T V E, L/min V T, L F R, breaths/min Paco 2, mm Hg Pao 2, mm Hg Petco 2, mm Hg Paetco 2,mmHg Alveolar slope, %CO 2 /L MWD, m (n 38) Borg at rest (n 38) Borg after 6-MWT (n 38) MWD 6-minute walk distance; F R breathing frequency; mpap mean pulmonary artery pressure; Paco 2 arterial pressure of carbon dioxide; Pao 2 arterial oxygen pressure; Petco 2 end tidal pressure of carbon doixide; Paetco 2 arterial-end tidal pressure of carbon dioxide difference; PEA pulmonary endarterectomy; TPR total pulmonary resistance; V D absolute dead space; V D /V T dead space ventilation; V D,alv /V T alveolar dead space ventilation; V D,anat /V T anatomical dead space ventilation; V E expired ventilation; V T tidal volume. induced pulmonary hypertension presented disabling impairment of exercise tolerance and had angiographic evidence for proximal chronic thromboembolic occlusion of at least 2 lobes. Asymptomatic coronary artery disease was present in 2 patients, who had a significant stenosis in the left anterior descending coronary artery and the right coronary artery, respectively. Dead Space Ventilation Preoperatively, V D /V T was elevated and correlated significantly with the hemodynamic severity of disease (mpap: r 0.49; TPR: r 0.53, both p 0.001); in line, in the 6 patients with exercise-induced pulmonary hypertension, V D /V T was compared with in the other patients, which was significantly lower (p 0.005). The shunt independent V D /V T, that was calculated in a subgroup of 22 consecutive patients only did not differ from the Bohr-Enghoff V D /V T, at vs (r 0.93, p 0.001). In line with this observation, the average shunt (Q S /Q T ) remained below the reported critical value of 0.20 ( ) [22]. Preoperative Dyspnea Preoperatively, the mean Borg score at rest in 38 patients (Table 1) was 1.1, ranging from no dyspnea (Borg score 0) to mild dyspnea (Borg score 3). The reported Borg score after exercise (6-MWT) increased to a mean of 4.6 (range 2 to 8), which was significant (p 0.001). Both resting and postexercise Borg scores correlated significantly with V D /V T (r 0.35, p 0.05 and r 0.44, p 0.01, respectively). In contrast, neither resting nor postexercise Borg score correlated with any of the variables reflecting the hemodynamic severity of disease; the best correlation reached r and p for the preexercise Borg score and PVR. The NYHA functional class correlated with dead space ventilation (V D /V T : r 0.34, p 0.05; Fig 1). In contrast to both Borg scores, the NYHA functional class also correlated significantly with the hemodynamic severity of disease (mpap: r 0.55; TPR: r 0.50; both p 0.001). By multivariate linear regression analysis, however, mpap only was shown to be independently associated with the reported NYHA functional class. (model: r , p 0.001; 0.51, p 0.001). Effect of PEA on Dead Space and Dyspnea The effects of PEA are summarized in Table 1. Four patients died postoperatively, 2 because of progressive right heart failure caused by persistent pulmonary hypertension and 2 due to postoperative massive alveolar hemorrhage. In the other 50 patients, mpap and TPR decreased significantly after PEA. However, residual pulmonary hypertension directly after PEA (by definition, mpap 25 mm Hg) was observed in 17 patients, 7 of whom had mpap 30 mm Hg. Follow-up dead space data, 1 year after PEA, were available in 47 of the 50 survivors. Follow-up was too exhaustive for 3 patients who had severe residual pulmonary hypertension. After PEA, dead space ventilation decreased and normalized in 29 patients (62%). Changes ( ) inv D /V T did not correlate with the observed changes in pulmonary hemodynamics ( mpap: r 0.22; TPR: r 0.18). Individual changes in resting Borg score were significantly correlated to changes in dead space ventilation (r 0.39, p 0.05) and absolute dead space (r 0.54, p GENERAL THORACIC Fig 1. Preoperative dead space ventilation (V D /V T ) and mean pulmonary arterial pressure (mpap) against New York Heart Association (NYHA functional class). Error bars show the standard deviation.

4 GENERAL THORACIC 350 VAN DER PLAS ET AL Ann Thorac Surg DEAD SPACE AND DYSPNEA AFTER PEA 2010;89: Fig 2. Change in absolute dead space (Delta V D ) and change in mean pulmonary arterial pressure (Delta mpap) against changes in Borg score at rest (Delta Borg) ) as well as mpap (r 0.41, p 0.02). In a multivariate analysis, V D and mpap were independently associated with patient-reported changes in resting Borg score (Fig 2). The Borg score after exercise decreased significantly, but the observed changes did not correlate with changes in V D /V T,V D, or the hemodynamic severity of disease. Possible relations, however, might have been obscured because the distance walked in the 6-MWT increased significantly in these patients. NYHA functional class improved in 46 of the 50 surviving patients. NYHA remained constant in 4 patients, 2 of whom had residual pulmonary hypertension. All other patients with residual pulmonary hypertension, however, did improve in NYHA functional class. The change in NYHA functional class ( NYHA) 1 year after PEA correlated significantly with the changes in dead space ventilation (r 0.34, p 0.05) and absolute dead space (r 0.64, p 0.001), as well as the hemodynamic improvement noted by mpap (r 0.54, p 0.001), and TPR (r 0.33, p 0.05). By multivariate linear regression analysis V D and mpap were significantly associated with the reported change in NYHA functional class (Model: r , p 0.001; V D : 0.51, p 0.001; mpap: 0.42, p 0.001; Fig 3). Comment In the present study, we demonstrated increased dead space ventilation in patients with CTEPH, which correlated significantly with hemodynamic severity of disease and patient-reported sensations of dyspnea. After PEA, dead space ventilation decreased and normalized in most patients. Moreover, the observed change in absolute dead space after PEA was independently associated with the reported changes in resting Borg score and NYHA functional class. Hence, although the primary objective of PEA is to lower right ventricular afterload, normalization of dead space by surgical removal of chronic thromboembolism contributed to the postoperative recovery of the symptomatic dyspnea. CTEPH results from incomplete resolution of the thromboembolic obstruction of the pulmonary vascular bed. Dead space ventilation increases as blood flow fails to perfuse ventilated lung. As a consequence, expired CO 2 pressure will decrease because air from nonperfused parts of the lung will mix with air from parts with a normal ventilation/perfusion ratio. The Bohr-Enghoff equation uses the difference between arterial and expired Pco 2 to quantify dead space ventilation. A V D /V T of 0.30 or less is considered normal [21], indicating that 30% of the expired air comes from parts of the respiratory system that do not contribute to gas exchange. The higher-than-normal V D /V T found in our study is consistent with a small previous study that reported increased Bohr dead space ventilation in patients with CTEPH [17] but is in contrast with studies that used the inert gas method to quantify dead space [27 30]. The applicability of the inert gas elimination technique in patients with CTEPH can be questioned. Petrini and colleagues [31] showed that the inert gas elimination technique will underestimate dead space when, as in CTEPH, both serial and parallel dead space coexist, because the analysis does not account for reinspiration of gas from the common dead space [31]. A comprehensive cardiorespiratory system model found the Bohr-Enghoff equation, on the other hand, was a reliable tool to estimate dead space ventilation, even when alveolar dead space and ventilation perfusion ratio distribution vary [32]. After PEA, dead space ventilation decreased. Because PEA does not affect the anatomic dead space, the observed decrease in dead space ventilation must be the consequence of a decrease in alveolar dead space. PEA relieves the thromboembolic obstruction of the pulmo- Fig 3. Change in absolute dead space (Delta V D ) and change in mean pulmonary arterial pressure (Delta mpap) against changes in NYHA functional class (Delta NYHA).

5 Ann Thorac Surg VAN DER PLAS ET AL 2010;89: DEAD SPACE AND DYSPNEA AFTER PEA nary vascular bed, thereby reestablishing pulmonary perfusion. In line, earlier studies demonstrated improvements in lung perfusion, ventilation/perfusion relationships, and gas exchange after PEA [16, 17]. In view of our findings, the failure of Kapitan and coworkers [17] to show a significant decrease in dead space ventilation is most likely the consequence of the small number of patients (n 9) studied. Surprisingly, the observed changes in dead space ventilation in our current study were not related to changes in hemodynamic severity of disease. It might be argued that the changes in hemodynamics and dead space ventilation are likely to be interdependent; after all, it is the improved pulmonary perfusion that causes the decrease in dead space ventilation. However, Tanabe and coworkers [16] showed an independent development of hemodynamic improvement and improvements in gas exchange over time after the operation. Where significant hemodynamic improvements were observed shortly after PEA, improvements in gas exchange were obtained over a longer period of 6 to 24 months. This might explain why both hemodynamic changes and changes in dead space ventilation were independently associated with changes in dyspnea in a multivariate analysis. Preoperatively, dyspnea at rest and after submaximal exercise (6-MWT), as assessed by the patient-reported Borg score, correlated with dead space ventilation but not with the hemodynamic severity of disease. Dyspnea includes several qualitatively distinct sensations that can arise from different pathophysiologic mechanisms [33, 34]. Increased dead space ventilation, through failure to perfuse areas of ventilated lung, may give rise to an increased ventilatory demand. This will contribute to an increase in respiratory motor output with a corresponding increase in the sense of effort, that is, the work of breathing. Respiratory-related sensation of dyspnea should, however, always be considered in its context. Symptoms of respiration-related dyspnea are more likely to be reported when hyperpnea occurs at rest, and as such cannot be accounted for by an increase in physical activity [34]. This seems to be consonant with our finding that dead space ventilation is in particular related to resting dyspnea sensation, assessed by the resting Borg score. Although the distance walked in the 6-MWT was previously shown to be significantly correlated to the hemodynamic severity of disease [14], our findings indicate that symptomatic dyspnea after submaximal exercise (6-MWT) appears mostly to be determined by an increased ventilatory demand due to increased dead space ventilation. Preoperatively, NYHA functional class was independently associated with the hemodynamic severity of disease only. In contrast to the Borg score, NYHA functional class classifies dyspnea at distinct levels of exercise and takes into account impaired (maximal) exercise tolerance. As a functional classification, it classifies dyspnea at the level of exercise limitation; as such, it represents the ability of patients to perform exercise. In CTEPH, exercise tolerance appears largely determined by circulatory limitations [14]. Exercise limitation, however, was not the subject of the present study. Previous studies in patients with idiopathic pulmonary arterial hypertension, however, appear to support this hypothesis [6, 35]. Postoperatively, changes in both Borg score at rest and NYHA functional class were related to changes in absolute dead space, but not to changes in dead space ventilation. Interestingly, we observed a decrease in ventilation after PEA, which was shown to be primarily the consequence of a decrease in tidal volume rather than breathing frequency. Dead space ventilation represents absolute dead space expressed as percentage of tidal volume ( V D /V T ); as a consequence of an absolute decrease in tidal volume, the improvement in dead space ventilation induced by PEA will be underestimated. As such, changes in absolute dead space may more closely reflect the increased blood flow through the pulmonary vascular bed after PEA than dead space ventilation. Some methodologic aspects of our study need comment. The lack of hemodynamic data at 1 year after PEA may be considered a limitation. As a result, it is difficult to distinguish the contribution of improved hemodynamics or cardiac function vs improvement in dead space ventilation to symptomatic patient improvement. As mentioned earlier, however, hemodynamic improvement and improvements in gas exchange develop independently over time after PEA. Hemodynamic improvements were observed shortly after PEA, and improvements in gas exchange were obtained over a longer period of 6 to 24 months. The delay in measurements of hemodynamic variables directly after PEA and the assessment of dyspnea and dead space ventilation 1 year later might therefore not have been of major influence. In conclusion, dead space ventilation was increased in CTEPH and decreased significantly after PEA. Preoperatively, sensations of dyspnea as assessed by the patientreported Borg score were primarily associated with increases in dead space ventilation. On the other hand, NYHA functional class, which classifies dyspnea at different levels of exercise and takes impaired exercise tolerance into account, appeared mainly determined by the hemodynamic severity of disease. Changes in dyspnea after PEA, such as resting Borg score and NYHA functional class, were independently associated with both the decrease in absolute dead space and the hemodynamic improvement. From our findings we conclude that although not the primary objective of PEA, normalization of dead space by surgical removal of chronic thromboembolism contributes to the postoperative recovery of symptomatic dyspnea. We would like to thank Niesje Verhey for her technical assistance and Harm Jan Bogaard and Peter Sterk for their support and critical review of the manuscript. References Fedullo PF, Auger WR, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001;345: GENERAL THORACIC

6 GENERAL THORACIC 352 VAN DER PLAS ET AL Ann Thorac Surg DEAD SPACE AND DYSPNEA AFTER PEA 2010;89: Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulation 2006; 113: Jamieson SW, Kapelanski DP. Pulmonary endarterectomy. Curr Probl Surg 2000;37: Viner SM, Bagg BR, Auger WR, Ford GT. The management of pulmonary hypertension secondary to chronic thromboembolic disease. Prog Cardiovasc Dis 1994;37: Wasserman K, Hansen JE, Sue DY, Casaburi R, Whipp BJ. Principles of exercise testing and interpretation. 3rd ed. New York: Lippincott Williams & Wilkins; Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 2001;104: Jamieson SW, Kapelanski DP, Sakakibara N, et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 2003;76: Kramm T, Mayer E, Dahm M, et al. Long-term results after thromboendarterectomy for chronic pulmonary embolism. Eur J Cardiothorac Surg 1999;15: Zoia MC, D Armini AM, Beccaria M, et al. Mid term effects of pulmonary thromboendarterectomy on clinical and cardiopulmonary function status. Thorax 2002;57: D Armini AM, Cattadori B, Monterosso C, et al. Pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension: hemodynamic characteristics and changes. Eur J Cardiothorac Surg 2000;18: Archibald CJ, Auger WR, Fedullo PF, et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med 1999;160: Mayer E, Dahm M, Hake U, et al. Mid-term results of pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg 1996;61: Mayer E, Klepetko W. Techniques and outcomes of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006;3: Reesink HJ, van der Plas MN, Verhey NE, van Steenwijk RP, Kloek JJ, Bresser P. Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg 2007;133: Reesink HJ, Marcus JT, Tulevski II, et al. Reverse right ventricular remodeling after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: utility of magnetic resonance imaging to demonstrate restoration of the right ventricle. J Thorac Cardiovasc Surg 2007;133: Tanabe N, Okada O, Nakagawa Y, et al. The efficacy of pulmonary thromboendarterectomy on long-term gas exchange. Eur Respir J 1997;10: Kapitan KS, Clausen JL, Moser KM. Gas exchange in chronic thromboembolism after pulmonary thromboendarterectomy. Chest 1990;98: Auger WR, Fedullo PF, Moser KM, Buchbinder M, Peterson KL. Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography. Radiology 1992;182: Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43(12 suppl S):40 7S. 20. Enghoff H. Volumen inefficax, Bemerkungen zur Frage des schadlichen Raumes. Upsala Lakareforen Forh 1934;44: Hughes JMB. Pulmonary gas exchange. In: Hughes JMB (ed). Lung Function tests. Physiological principles and clinical applications. 3 edition. London, UK: Harcourt Publishers Ltd; 2001: Kuwabara S, Duncalf D. Effect of anatomic shunt on physiologic deadspace-to-tidal volume ratio a new equation. Anesthesiology 1969;31: Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004;43(12 suppl S):5 12S. 24. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14: ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166: Fedullo PF, Auger WR, Channick RN, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Clin Chest Med 2001;22: Kapitan KS, Buchbinder M, Wagner PD, Moser KM. Mechanisms of hypoxemia in chronic thromboembolic pulmonary hypertension. Am Rev Respir Dis 1989;139: Dantzker DR, Bower JS. Mechanisms of gas exchange abnormality in patients with chronic obliterative pulmonary vascular disease. J Clin Invest 1979;64: Dantzker DR, Bower JS. Pulmonary vascular tone improves VA/Q matching in obliterative pulmonary hypertension. J Appl Physiol 1981;51: Dantzker DR, D Alonzo GE, Bower JS, Popat K, Crevey BJ. Pulmonary gas exchange during exercise in patients with chronic obliterative pulmonary hypertension. Am Rev Respir Dis 1984;130: Petrini MF, Robertson HT, Hlastala MP. Interaction of series and parallel dead space in the lung. Respir Physiol 1983;54: Tang Y, Turner MJ, Baker AB. Effects of alveolar dead-space, shunt and V/Q distribution on respiratory dead-space measurements. Br J Anaesth 2005;95: Manning HL, Schwartzstein RM. Pathophysiology of dyspnea. N Engl J Med 1995;333: Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med 1999;159: Yasunobu Y, Oudiz RJ, Sun XG, Hansen JE, Wasserman K. End-tidal PCO 2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest 2005; 127:

Ann Vasc Dis Vol. 6, No. 3; 2013; pp Online August 12, Annals of Vascular Diseases doi: /avd.oa Original Article

Ann Vasc Dis Vol. 6, No. 3; 2013; pp Online August 12, Annals of Vascular Diseases doi: /avd.oa Original Article Ann Vasc Dis Vol. 6, No. 3; 2013; pp 578 582 Online August 12, 2013 2013 Annals of Vascular Diseases doi:10.3400/avd.oa.13-00056 Original Article Respiratory and Hemodynamic Changes in Patients with Chronic

More information

Pulmonary Hypertension Surgical Options. Primary pulmonary hypertension. Transplantation. Thromboembolic disease Endarterectomy

Pulmonary Hypertension Surgical Options. Primary pulmonary hypertension. Transplantation. Thromboembolic disease Endarterectomy Stuart W. Jamieson Cardiothoracic Surgery University of California San Diego Chronic Thromboembolic Pulmonary Hypertension Pulmonary Hypertension Surgical Options Primary pulmonary hypertension Transplantation

More information

Selection criteria for PEA (UCSD)

Selection criteria for PEA (UCSD) Chirurgische behandeling van chronische longembolen Pulmonale Thrombendarterectomie PTEA Selection criteria for PEA (UCSD) NYHA 3-4 PVR > 300 dynes.sec.cm-5 accessibility of the thrombi - strictures (main,

More information

Plasma Brain Natriuretic Peptide as a Noninvasive Marker for Efficacy of Pulmonary Thromboendarterectomy

Plasma Brain Natriuretic Peptide as a Noninvasive Marker for Efficacy of Pulmonary Thromboendarterectomy Plasma Brain Natriuretic Peptide as a Noninvasive Marker for Efficacy of Pulmonary Thromboendarterectomy Noritoshi Nagaya, MD, Motomi Ando, MD, Hideo Oya, MD, Yutaka Ohkita, MD, Shingo Kyotani, MD, Fumio

More information

Long-Term Recovery of Exercise Ability After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension

Long-Term Recovery of Exercise Ability After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension Long-Term Recovery of Exercise Ability After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension Hitoshi Matsuda, MD, Hitoshi Ogino, MD, Kenji Minatoya, MD, Hiroaki Sasaki, MD, Norifumi

More information

Real life management of CTEPH: patient case

Real life management of CTEPH: patient case 2 nd International Congress on cardiovascular imaging in clinical practice k Real life management of CTEPH: patient case Anastasia Anthi Pulmonary Hypertension Clinic, Attikon University Hospital, Athens

More information

CTEPH. surgical treatment. Ph. Dartevelle, E. Fadel, S. Mussot, D. Fabre, O. Mercier and G. Simonneau PARIS-SUD UNIVERSITY

CTEPH. surgical treatment. Ph. Dartevelle, E. Fadel, S. Mussot, D. Fabre, O. Mercier and G. Simonneau PARIS-SUD UNIVERSITY CTEPH surgical treatment Ph. Dartevelle, E. Fadel, S. Mussot, D. Fabre, O. Mercier and G. Simonneau MARIE-LANNELONGUE HOSPITAL BICETRE HOSPITAL PARIS-SUD UNIVERSITY Clinical Classification of PH G Simonneau

More information

Pulmonary thromboendarterectomy (PTE) is indicated for

Pulmonary thromboendarterectomy (PTE) is indicated for Pulmonary Thromboendarterectomy Steven R. Meyer, MD, PhD, and Christopher G.A. McGregor, MB, FRCS, MD (Hons) Division of Cardiovascular Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota.

More information

The management of chronic thromboembolic pulmonary

The management of chronic thromboembolic pulmonary Technique of Pulmonary Thromboendarterectomy Isabelle Opitz, MD, and Marc de Perrot, MD, MSc, FRCSC Toronto Pulmonary Endarterectomy Program, Toronto General Hospital, Ontario, Canada. Address reprint

More information

DISTAL PULMONARY THROMBOENDARTERECTOMY: IS IT WORTH IT?

DISTAL PULMONARY THROMBOENDARTERECTOMY: IS IT WORTH IT? DISTAL PULMONARY THROMBOENDARTERECTOMY: IS IT WORTH IT? Bob Moraca, MD Associate Professor of Surgery Surgical Director of The CTEPH Program Director of Thoracic Aortic and Arrhythmia Surgery Allegheny

More information

Vascular Medicine. Pulmonary Hypertensive Medical Therapy in Chronic Thromboembolic Pulmonary Hypertension Before Pulmonary Thromboendarterectomy

Vascular Medicine. Pulmonary Hypertensive Medical Therapy in Chronic Thromboembolic Pulmonary Hypertension Before Pulmonary Thromboendarterectomy Vascular Medicine Pulmonary Hypertensive Medical Therapy in Chronic Thromboembolic Pulmonary Hypertension Before Pulmonary Thromboendarterectomy Kurt W. Jensen, MD; Kim M. Kerr, MD; Peter F. Fedullo, MD;

More information

Quantifying the learning curve for pulmonary thromboendarterectomy

Quantifying the learning curve for pulmonary thromboendarterectomy Sihag et al. Journal of Cardiothoracic Surgery (2017) 12:121 DOI 10.1186/s13019-017-0686-1 RESEARCH ARTICLE Open Access Quantifying the learning curve for pulmonary thromboendarterectomy Smita Sihag 1,4*,

More information

Αγγειοπλαστική των πνευμονικών αρτηριών στην χρόνια θρομβοεμβολική πνευμονική υπέρταση. Παρόν και μέλλον

Αγγειοπλαστική των πνευμονικών αρτηριών στην χρόνια θρομβοεμβολική πνευμονική υπέρταση. Παρόν και μέλλον Αγγειοπλαστική των πνευμονικών αρτηριών στην χρόνια θρομβοεμβολική πνευμονική υπέρταση. Παρόν και μέλλον Παναγιώτης Καρυοφύλλης Επιμελητής Β Ωνάσειο Καρδιοχ/κό Κέντρο CTEPH is an obstructive disease Pulmonary

More information

ORIGINAL ARTICLE. Editorial p 320. Methods. Pulmonary Circulation. 476 YAMAKI S et al.

ORIGINAL ARTICLE. Editorial p 320. Methods. Pulmonary Circulation. 476 YAMAKI S et al. 476 YAMAKI S et al. Circulation Journal ORIGINAL ARTICLE Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp Pulmonary Circulation Histopathological Examination by Lung Biopsy

More information

Medical Therapy for Chronic Thromboembolic Pulmonary Hypertension

Medical Therapy for Chronic Thromboembolic Pulmonary Hypertension Medical Therapy for Chronic Thromboembolic Pulmonary Hypertension Josanna Rodriguez-Lopez, MD Pulmonary Hypertension and Thromboendarterectomy Program Massachusetts General Hospital Harvard Medical School

More information

Anjali Vaidya, MD, FACC, FASE, FACP Associate Director, Pulmonary Hypertension, Right Heart Failure, and Pulmonary Thromboendarterectomy Program

Anjali Vaidya, MD, FACC, FASE, FACP Associate Director, Pulmonary Hypertension, Right Heart Failure, and Pulmonary Thromboendarterectomy Program Anjali Vaidya, MD, FACC, FASE, FACP Associate Director, Pulmonary Hypertension, Right Heart Failure, and Pulmonary Thromboendarterectomy Program Advanced Heart Failure & Cardiac Transplant Temple University

More information

Pulmonary hypertension is a devastating. Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients

Pulmonary hypertension is a devastating. Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients Eur Respir J 2012; 39: 119 124 DOI: 10.1183/09031936.00109710 CopyrightßERS 2012 Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients S.J. Scheidl*, C. Englisch #, G. Kovacs*,

More information

Επεμβατικές στρατηγικές στην πνευμονική υπέρταση

Επεμβατικές στρατηγικές στην πνευμονική υπέρταση Επεμβατικές στρατηγικές στην πνευμονική υπέρταση Παναγιώτης Καρυοφύλλης Καρδιολόγος Ωνάσειο Καρδιοχειρουργικό Κέντρο Mortality in PAH 2015 ESC/ERS Guidelines. Treatment algorithm Since BAS is performed

More information

The efficacy of pulmonary thromboendarterectomy on long-term gas exchange

The efficacy of pulmonary thromboendarterectomy on long-term gas exchange Eur Respir J 1997; 10: 2066 2072 DOI: 10.1183/09031936.97.10092066 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1997 European Respiratory Journal ISSN 0903-1936 The efficacy of pulmonary

More information

Exercise Stress Testing: Cardiovascular or Respiratory Limitation?

Exercise Stress Testing: Cardiovascular or Respiratory Limitation? Exercise Stress Testing: Cardiovascular or Respiratory Limitation? Marshall B. Dunning III, Ph.D., M.S. Professor of Medicine & Physiology Medical College of Wisconsin What is exercise? Physical activity

More information

Primary pulmonary hypertension (PPH) is a progressive

Primary pulmonary hypertension (PPH) is a progressive Exercise Pathophysiology in Patients With Primary Pulmonary Hypertension Xing-Guo Sun, MD; James E. Hansen, MD; Ronald J. Oudiz, MD; Karlman Wasserman, MD, PhD Background Patients with primary pulmonary

More information

Primary pulmonary hypertension (PPH) is a rapidly progressive

Primary pulmonary hypertension (PPH) is a rapidly progressive Effects of Iloprost Inhalation on Exercise Capacity and Ventilatory Efficiency in Patients With Primary Pulmonary Hypertension Roland Wensel, MD; Christian F. Opitz, MD; Ralf Ewert, MD; Leonhard Bruch,

More information

1. When a patient fails to ventilate or oxygenate adequately, the problem is caused by pathophysiological factors such as hyperventilation.

1. When a patient fails to ventilate or oxygenate adequately, the problem is caused by pathophysiological factors such as hyperventilation. Chapter 1: Principles of Mechanical Ventilation TRUE/FALSE 1. When a patient fails to ventilate or oxygenate adequately, the problem is caused by pathophysiological factors such as hyperventilation. F

More information

Annual Congress of the European Society of Cardiology Munich, August

Annual Congress of the European Society of Cardiology Munich, August Annual Congress of the European Society of Cardiology Munich, August 26 2012 Gas exchange measurements during exercise show early pulmonary arterial hypertension in scleroderma patients Daniel Dumitrescu,

More information

Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension

Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension REVIEW CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension David Jenkins Affiliation:

More information

Surgical Management in Chronic Thromboembolic Pulmonary Hypertension. Michael Bates, MD, FACS Ochsner Health System, New Orleans, LA

Surgical Management in Chronic Thromboembolic Pulmonary Hypertension. Michael Bates, MD, FACS Ochsner Health System, New Orleans, LA Surgical Management in Chronic Thromboembolic Pulmonary Hypertension Michael Bates, MD, FACS Ochsner Health System, New Orleans, LA Disclosures No industry conflicts I am a surgeon and always disclose

More information

Riociguat for chronic thromboembolic pulmonary hypertension

Riociguat for chronic thromboembolic pulmonary hypertension Riociguat for chronic thromboembolic pulmonary hypertension This technology summary is based on information available at the time of research and a limited literature search. It is not intended to be a

More information

Patricia A. Thistlethwaite, MD, PhD, Aaron Kemp, BA, Lingling Du, MD, Michael M. Madani, MD, and Stuart W. Jamieson, MB, FRCS

Patricia A. Thistlethwaite, MD, PhD, Aaron Kemp, BA, Lingling Du, MD, Michael M. Madani, MD, and Stuart W. Jamieson, MB, FRCS Outcomes of pulmonary endarterectomy for treatment of extreme thromboembolic pulmonary hypertension Patricia A. Thistlethwaite, MD, PhD, Aaron Kemp, BA, Lingling Du, MD, Michael M. Madani, MD, and Stuart

More information

Alveolar-Arterial Oxygen Gradient in the Assessment of Acute Pulmonary Embolism*

Alveolar-Arterial Oxygen Gradient in the Assessment of Acute Pulmonary Embolism* Alveolar-Arterial Oxygen Gradient in the Assessment of Acute Pulmonary Embolism* Paul D. Stein, MD, FCCP; Samuel Z. Goldhaber, MD, FCCP; and jerald W. Henry, MS Purpose: The purpose of this investigation

More information

Chronic Thromboembolic Pulmonary Hypertention CTEPH

Chronic Thromboembolic Pulmonary Hypertention CTEPH Chronic Thromboembolic Pulmonary Hypertention CTEPH Medical Management Otto Schoch, Prof. Dr. Klinik für Pneumologie und Schlafmedizin Kantonsspital St.Gallen CTEPH: Medical Management Diagnostic aspects

More information

Severe pulmonary embolism: surgical aspects. Oliver Reuthebuch Clinic for Cardiac Surgery University Hospital Basel Switzerland

Severe pulmonary embolism: surgical aspects. Oliver Reuthebuch Clinic for Cardiac Surgery University Hospital Basel Switzerland Severe pulmonary embolism: surgical aspects Oliver Reuthebuch Clinic for Cardiac Surgery University Hospital Basel Switzerland Severe pulmonary embolism Acute pulmonary embolism Chronic pulmonary thromboembolism

More information

Exercise stroke volume and heart rate response differ in right and left heart failure

Exercise stroke volume and heart rate response differ in right and left heart failure European Journal of Heart Failure (2010) 12, 716 720 doi:10.1093/eurjhf/hfq062 Exercise stroke volume and heart rate response differ in right and left heart failure Herman Groepenhoff 1 *, Nico Westerhof

More information

OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO

OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO Subject Index ACE inhibitors, see Angiotensin-converting enzyme inhibitors Aging

More information

Chapter 1. Introduction

Chapter 1. Introduction Chapter 1 Introduction Introduction 9 Even though the first reports on venous thromboembolism date back to the 13 th century and the mechanism of acute pulmonary embolism (PE) was unraveled almost 150

More information

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease 136 PHYSIOLOGY CASES AND PROBLEMS Case 24 Chronic Obstructive Pulmonary Disease Bernice Betweiler is a 73-year-old retired seamstress who has never been married. She worked in the alterations department

More information

Chapter. Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension

Chapter. Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension Chapter 7 Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension P. Trip B. Girerd H.J. Bogaard F.S. de Man A. Boonstra G. Garcia M. Humbert D. Montani A. Vonk Noordegraaf Eur Respir

More information

todays practice of cardiopulmonary medicine

todays practice of cardiopulmonary medicine todays practice of cardiopulmonary medicine Concepts and Applications of Cardiopulmonary Exercise Testing* Karl T. Weber, M.D.; Joseph S. Janicki, Ph.D.; Patricia A. McElroy, M.D.; and Hanumanth K. Reddy,

More information

CHAPTER X - SECONDARY PULMONARY HYPERTENSION CHRONIC PULMONARY THROMBOEMBOLISM (HTP). PULMONARY THROMBENDARTERECTOMY

CHAPTER X - SECONDARY PULMONARY HYPERTENSION CHRONIC PULMONARY THROMBOEMBOLISM (HTP). PULMONARY THROMBENDARTERECTOMY CHAPTER X - SECONDARY PULMONARY HYPERTENSION CHRONIC PULMONARY THROMBOEMBOLISM (HTP). PULMONARY THROMBENDARTERECTOMY Walter KLEPETKO, PhD, VIENNA - AUSTRIA Marian GASPAR, PhD, TIMISOARA 10. 1. Definition.

More information

Submaximal exercise pulmonary gas exchange in left heart disease patients with different forms of pulmonary hypertension

Submaximal exercise pulmonary gas exchange in left heart disease patients with different forms of pulmonary hypertension Submaximal exercise pulmonary gas exchange in left heart disease patients with different forms of pulmonary hypertension Short Title: Pulmonary gas exchange in HF patients with PH Authors: * Bryan J. Taylor,

More information

State-of-the-art chronic thromboembolic pulmonary hypertension diagnosis and management

State-of-the-art chronic thromboembolic pulmonary hypertension diagnosis and management Eur Respir Rev 2012; 21: 123, 32 39 DOI: 10.1183/09059180.00009211 CopyrightßERS 2012 REVIEW State-of-the-art chronic thromboembolic pulmonary hypertension diagnosis and management D. Jenkins*, E. Mayer

More information

Dyspnea is a common exercise-induced

Dyspnea is a common exercise-induced MK pg 214 Mædica - a Journal of Clinical Medicine STATE-OF-THE-ART Cardiopulmonary exercise testing in differential diagnosis of dyspnea Nora TOMA, MD; Gabriela BICESCU, MD, PhD; Raluca ENACHE, MD; Ruxandra

More information

ΔΙΑΓΝΩΣΗ ΚΑΙ ΘΕΡΑΠΕΙΑ ΤΗΣ ΧΡΟΝΙΑΣ ΘΡΟΜΒΟΕΜΒΟΛΙΚΗΣ ΥΠΕΡΤΑΣΗΣ (CTEPH)

ΔΙΑΓΝΩΣΗ ΚΑΙ ΘΕΡΑΠΕΙΑ ΤΗΣ ΧΡΟΝΙΑΣ ΘΡΟΜΒΟΕΜΒΟΛΙΚΗΣ ΥΠΕΡΤΑΣΗΣ (CTEPH) Aristotle University of Thessaloniki Cardiology Clinic, AHEPA Hospital ΔΙΑΓΝΩΣΗ ΚΑΙ ΘΕΡΑΠΕΙΑ ΤΗΣ ΧΡΟΝΙΑΣ ΘΡΟΜΒΟΕΜΒΟΛΙΚΗΣ ΥΠΕΡΤΑΣΗΣ (CTEPH) Charalampos I. Karvounis, MD Professor of Cardiology Aristotle

More information

Lecture Notes. Chapter 2: Introduction to Respiratory Failure

Lecture Notes. Chapter 2: Introduction to Respiratory Failure Lecture Notes Chapter 2: Introduction to Respiratory Failure Objectives Define respiratory failure, ventilatory failure, and oxygenation failure List the causes of respiratory failure Describe the effects

More information

Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension

Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension REVIEW CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension David Jenkins 1, Michael Madani 2, Elie Fadel 3, Andrea

More information

Screening for CETPH after acute pulmonary embolism: is it needed? Menno V. Huisman Department of Vascular Medicine LUMC Leiden

Screening for CETPH after acute pulmonary embolism: is it needed? Menno V. Huisman Department of Vascular Medicine LUMC Leiden Screening for CETPH after acute pulmonary embolism: is it needed? Menno V. Huisman Department of Vascular Medicine LUMC Leiden m.v.huisman@lumc.nl Background CETPH Chronic Thrombo Embolic Pulmonary Hypertension

More information

Surgical treatment of chronic thromboembolic pulmonary hypertension

Surgical treatment of chronic thromboembolic pulmonary hypertension Review article Peer reviewed article SWISS MED WKLY 2006;136:491 497 www.smw.ch 491 Surgical treatment of chronic thromboembolic pulmonary hypertension Eckhard Mayer Department of Cardiothoracic and Vascular

More information

The Pursuit of Minimally Invasive Pulmonary Thromboendarterectomy

The Pursuit of Minimally Invasive Pulmonary Thromboendarterectomy The Pursuit of Minimally Invasive Pulmonary Thromboendarterectomy Michael M Madani, MD, FACS Professor & Chief, Cardiovascular & Thoracic Surgery Director, UCSD - Surgery University of California San Diego

More information

Chapter 38: Pulmonary Circulation, Pulmonary Edema, Pleural Fluid UNIT VII. Slides by Robert L. Hester, PhD

Chapter 38: Pulmonary Circulation, Pulmonary Edema, Pleural Fluid UNIT VII. Slides by Robert L. Hester, PhD UNIT VII Chapter 38: Pulmonary Circulation, Pulmonary Edema, Pleural Fluid Slides by Robert L. Hester, PhD Objectives Describe the pulmonary circulation Describe the pulmonary blood pressures List the

More information

FOLLOW-UP MEDICAL CARE OF SERVICE MEMBERS AND VETERANS CARDIOPULMONARY EXERCISE TESTING

FOLLOW-UP MEDICAL CARE OF SERVICE MEMBERS AND VETERANS CARDIOPULMONARY EXERCISE TESTING Cardiopulmonary Exercise Testing Chapter 13 FOLLOW-UP MEDICAL CARE OF SERVICE MEMBERS AND VETERANS CARDIOPULMONARY EXERCISE TESTING WILLIAM ESCHENBACHER, MD* INTRODUCTION AEROBIC METABOLISM ANAEROBIC METABOLISM

More information

Chronic post-embolic pulmonary hypertension: a new target for medical therapies?

Chronic post-embolic pulmonary hypertension: a new target for medical therapies? REVIEW RARE DISEASE AND ORPHAN DRUGS Chronic post-embolic pulmonary hypertension: a new target for medical therapies? Marion Delcroix Affiliations: Respiratory Division, University Hospitals and Dept of

More information

Objective: Prepare NBRC candidate for CRT and WRT Content Outline

Objective: Prepare NBRC candidate for CRT and WRT Content Outline STRESS TEST AND HEMODYNAMICS Lois Rowland, MS, RRT-NPS, RPFT, FAARC Objective: Prepare NBRC candidate for CRT and WRT Content Outline Perform, evaluate patient response to, interpret results from: Stress

More information

Pulmonary circulation. Lung Blood supply : lungs have a unique blood supply system :

Pulmonary circulation. Lung Blood supply : lungs have a unique blood supply system : Dr. Ali Naji Pulmonary circulation Lung Blood supply : lungs have a unique blood supply system : 1. Pulmonary circulation 2. Bronchial circulation 1- Pulmonary circulation : receives the whole cardiac

More information

Nothing to Disclose. Severe Pulmonary Hypertension

Nothing to Disclose. Severe Pulmonary Hypertension Severe Ronald Pearl, MD, PhD Professor and Chair Department of Anesthesiology Stanford University Rpearl@stanford.edu Nothing to Disclose 65 year old female Elective knee surgery NYHA Class 3 Aortic stenosis

More information

PA Catheters - Useful or Not

PA Catheters - Useful or Not PA Catheters - Useful or Not Perioperative in Liver Transplantation ILTS/ASA, San Francisco, 2003 Claus U. Niemann, MD Department of Anesthesia and Perioperative Division of Liver Transplantation University

More information

PREOPERATIVE CARDIOPULMONARY ASSESSMENT FOR LIVER TRANSPLANTATION James Y. Findlay Mayo Clinic College of Medicine, Rochester, MN, USA.

PREOPERATIVE CARDIOPULMONARY ASSESSMENT FOR LIVER TRANSPLANTATION James Y. Findlay Mayo Clinic College of Medicine, Rochester, MN, USA. PREOPERATIVE CARDIOPULMONARY ASSESSMENT FOR LIVER TRANSPLANTATION James Y. Findlay Mayo Clinic College of Medicine, Rochester, MN, USA Introduction Liver transplantation (LT) has gone from being a high-risk

More information

Mechanical Ventilation & Cardiopulmonary Interactions: Clinical Application in Non- Conventional Circulations. Eric M. Graham, MD

Mechanical Ventilation & Cardiopulmonary Interactions: Clinical Application in Non- Conventional Circulations. Eric M. Graham, MD Mechanical Ventilation & Cardiopulmonary Interactions: Clinical Application in Non- Conventional Circulations Eric M. Graham, MD Background Heart & lungs work to meet oxygen demands Imbalance between supply

More information

Pharmacy Management Drug Policy

Pharmacy Management Drug Policy SUBJECT: Pulmonary Arterial Hypertension (PAH) POLICY NUMBER: Pharmacy-42 Clinical criteria used to make utilization review decisions are based on credible scientific evidence published in peer reviewed

More information

Index. Note: Page numbers of article titles are in boldface type

Index. Note: Page numbers of article titles are in boldface type Index Note: Page numbers of article titles are in boldface type A Acute coronary syndrome, perioperative oxygen in, 599 600 Acute lung injury (ALI). See Lung injury and Acute respiratory distress syndrome.

More information

Pathophysiology Department

Pathophysiology Department UNIVERSITY OF MEDICINE - PLOVDIV Pathophysiology Department 15A Vasil Aprilov Blvd. Tel. +359 32 602311 Algorithm for interpretation of submaximal exercise tests in children S. Kostianev 1, B. Marinov

More information

Chronic thromboembolic pulmonary hypertension (CTEPH) and the essential role of imaging specialists PP-ADE-ALL

Chronic thromboembolic pulmonary hypertension (CTEPH) and the essential role of imaging specialists PP-ADE-ALL Chronic thromboembolic pulmonary hypertension (CTEPH) and the essential role of imaging specialists PP-ADE-ALL-0086-2 CTEPH and the essential role of imaging specialists 1 Introduction, and signs, symptoms

More information

PULMONARY HYPERTENSION

PULMONARY HYPERTENSION PULMONARY HYPERTENSION REVIEW & UPDATE Olga M. Fortenko, M.D. Pulmonary & Critical Care Medicine Pulmonary Vascular Diseases Sequoia Hospital 650-216-9000 Olga.Fortenko@dignityhealth.org Disclosures None

More information

Describe regional differences in pulmonary blood flow in an upright person. Describe the major functions of the bronchial circulation

Describe regional differences in pulmonary blood flow in an upright person. Describe the major functions of the bronchial circulation OBJECTIVES Describe regional differences in pulmonary blood flow in an upright person Define zones I, II, and III in the lung, with respect to pulmonary vascular pressure and alveolar pressure Describe

More information

WHAT IS CTEPH. Helping you understand your type of PH. Provided by Bayer to help education of the PH community

WHAT IS CTEPH. Helping you understand your type of PH. Provided by Bayer to help education of the PH community Educational program by Material endorsed by WHAT IS CTEPH Helping you understand your type of PH Provided by Bayer to help education of the PH community WHAT IS PH? lood travels from your heart to the

More information

Identification and Treatment of the Patient with Sleep Related Hypoventilation

Identification and Treatment of the Patient with Sleep Related Hypoventilation Identification and Treatment of the Patient with Sleep Related Hypoventilation Hillary Loomis-King, MD Pulmonary and Critical Care of NW MI Munson Sleep Disorders Center X Conflict of Interest Disclosures

More information

Effects of Exercise Training on Abnormal Ventilatory Responses to Exercise in Patients with Chronic Heart Failure

Effects of Exercise Training on Abnormal Ventilatory Responses to Exercise in Patients with Chronic Heart Failure EXERCISE AND ABNORMAL VENTILATION IN CHF CHF SEPTEMBER/OCTOBER 2000 243 Effects of Exercise Training on Abnormal Ventilatory Responses to Exercise in Patients with Chronic Heart Failure Patients with chronic

More information

Management of Heart Failure in Adult with Congenital Heart Disease

Management of Heart Failure in Adult with Congenital Heart Disease Management of Heart Failure in Adult with Congenital Heart Disease Ahmed Krimly Interventional and ACHD consultant King Faisal Cardiac Center National Guard Jeddah Background 0.4% of adults have some form

More information

Pharmacy Management Drug Policy

Pharmacy Management Drug Policy SUBJECT: POLICY NUMBER: PHARMACY-42 EFFECTIVE DATE: 6/2005 LAST REVIEW DATE: 4/19/2018 If the member s subscriber contract excludes coverage for a specific service or prescription drug, it is not covered

More information

Pulmonary Endarterectomy: Assessment of Operability, Surgical Description, and Post-op Care

Pulmonary Endarterectomy: Assessment of Operability, Surgical Description, and Post-op Care Pulmonary Endarterectomy: Assessment of Operability, Surgical Description, and Post-op Care David Poch, MD Division of Pulmonary and Critical Care University of California San Diego La Jolla, CA Victor

More information

Chronic Thromboembolic and Pulmonary Arterial Hypertension Share Acute Vasoreactivity Properties*

Chronic Thromboembolic and Pulmonary Arterial Hypertension Share Acute Vasoreactivity Properties* CHEST Chronic Thromboembolic and Pulmonary Arterial Hypertension Share Acute Vasoreactivity Properties* Silvia Ulrich, MD; Manuel Fischler, MD; Rudolf Speich, MD, FCCP; Vladimir Popov, MD; Marco Maggiorini,

More information

WHAT IS. Helping your patients understand their type of PH. Educational program by. Material endorsed by

WHAT IS. Helping your patients understand their type of PH. Educational program by. Material endorsed by Educational program by Material endorsed by WHAT IS CTEPH Helping your patients understand their type of PH Provided by Bayer to help education of the PH community What is ph? B lood travels from your

More information

Role of Combination PAH Therapies

Role of Combination PAH Therapies Role of Combination PAH Therapies Ronald J. Oudiz, MD, FACP, FACC Associate Professor of Medicine, David Geffen School of Medicine at UCLA Director, Liu Center for Pulmonary Hypertension Los Angeles Biomedical

More information

Effect of exercise mode on oxygen uptake and blood gases in COPD patients

Effect of exercise mode on oxygen uptake and blood gases in COPD patients Respiratory Medicine (2004) 98, 656 660 Effect of exercise mode on oxygen uptake and blood gases in COPD patients C.C. Christensen a,b, *, M.S. Ryg b, A. Edvardsen a,b, O.H. Skjønsberg a a Department of

More information

A comparison of pattern of breathing during incremental exercise in patients with pulmonary fibrosis and primary pulmonary hypertension

A comparison of pattern of breathing during incremental exercise in patients with pulmonary fibrosis and primary pulmonary hypertension American Journal of Internal Medicine 2013; 1(4): 31-35 Published online November 10, 2013 (http://www.sciencepublishinggroup.com/j/ajim) doi: 10.11648/j.ajim.20130104.12 A comparison of pattern of breathing

More information

James E. Hansen, MD, FCCP; Gaye Ulubay, MD; Bing Fai Chow, MD; Xing-Guo Sun, MD; and Karlman Wasserman, PhD, MD, FCCP

James E. Hansen, MD, FCCP; Gaye Ulubay, MD; Bing Fai Chow, MD; Xing-Guo Sun, MD; and Karlman Wasserman, PhD, MD, FCCP CHEST Original Research EXERCISE TESTING Mixed-Expired and End-Tidal CO 2 Distinguish Between Ventilation and Perfusion Defects During Exercise Testing in Patients With Lung and Heart Diseases* James E.

More information

ACTIVITY DESCRIPTION Target Audience Learning Objectives

ACTIVITY DESCRIPTION Target Audience Learning Objectives ACTIVITY DESCRIPTION Target Audience This continuing medical education activity is planned to meet the needs of primary care providers who can contribute to screening and early detection of CTEPH among

More information

Vixra JGSP 2013 (3) : Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia

Vixra JGSP 2013 (3) : Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia 1 Intensive Care Department, College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia 2 Rafik Hariri University Hospital, Beirut Lebanon Department of

More information

Correlation Between Partial Pressure of Arterial Carbon Dioxide and End Tidal Carbon Dioxide in Patients with Severe Alcohol Withdrawal

Correlation Between Partial Pressure of Arterial Carbon Dioxide and End Tidal Carbon Dioxide in Patients with Severe Alcohol Withdrawal ORIGINAL RESEARCH The Ochsner Journal 15:418 422, 2015 Ó Academic Division of Ochsner Clinic Foundation Correlation Between Partial Pressure of Arterial Carbon Dioxide and End Tidal Carbon Dioxide in Patients

More information

Dr. J. R. Rawal 1 ; Dr. H. S. Joshi 2 ; Dr. B. H. Roy 3 ; Dr. R. V. Ainchwar 3 ; Dr. S. S. Sahoo 3 ; Dr. A. P. Rawal 4 ; Dr. R. A.

Dr. J. R. Rawal 1 ; Dr. H. S. Joshi 2 ; Dr. B. H. Roy 3 ; Dr. R. V. Ainchwar 3 ; Dr. S. S. Sahoo 3 ; Dr. A. P. Rawal 4 ; Dr. R. A. (6) EFFECT OF ORAL SILDENAFIL ON RESIDUAL PULMONARY ARTERIAL HYPERTENSION IN PATIENTS FOLLOWING SUCCESSFUL PERCUTANEOUS BALLOON MITRAL VALVULOPLASTY (PBMV): SHORT TERM RESULTS IN 12 PATIENTS. Dr. J. R.

More information

Medical Policy and and and and

Medical Policy and and and and ARBenefits Approval: 10/12/2011 Effective Date: 01/01/2012 Revision Date: Code(s): 93799, Unlisted cardiovascular service or procedure Medical Policy Title: Percutaneous Transluminal Septal Myocardial

More information

WHAT IS CTEPH. Helping you understand your type of PH. Provided by Bayer to help education of the PH community

WHAT IS CTEPH. Helping you understand your type of PH. Provided by Bayer to help education of the PH community Educational program by Material endorsed by WHAT IS CTEPH Helping you understand your type of PH Provided by Bayer to help education of the PH community WHAT IS PH? lood travels from your heart to the

More information

Pulmonary Hypertension in 2012

Pulmonary Hypertension in 2012 Pulmonary Hypertension in 2012 Evan Brittain, MD December 7, 2012 Kingston, Jamaica VanderbiltHeart.com Disclosures None VanderbiltHeart.com Outline Definition and Classification of PH Hemodynamics of

More information

Omar Sami. Mustafa Khader. Yanal Shafaqouj

Omar Sami. Mustafa Khader. Yanal Shafaqouj 8 Omar Sami Mustafa Khader Yanal Shafaqouj Let us retrieve our discussion about the ventilation-perfusion ratio (V/Q). - When (V/Q) is Zero this means that no ventilation is taking place, V is Zero; bronchial

More information

Chapter 10. Prevalence and determinants of exertional dyspnea after acute pulmonary embolism

Chapter 10. Prevalence and determinants of exertional dyspnea after acute pulmonary embolism Chapter 10 Prevalence and determinants of exertional dyspnea after acute pulmonary embolism F.A. Klok, K.W. van Kralingen, A.P.J. van Dijk, F.H. Heyning, H.W. Vliegen and M.V. Huisman Submitted ABSTRACT

More information

Pulmonary Hypertension Perioperative Management

Pulmonary Hypertension Perioperative Management Pulmonary Hypertension Perioperative Management Bruce J Leone, MD Professor of Anesthesiology Chief, Neuroanesthesiology Vice Chair for Academic Affairs Mayo Clinic Jacksonville, Florida Introduction Definition

More information

Exercise Testing Interpretation in the Congenital Heart.

Exercise Testing Interpretation in the Congenital Heart. Interpretation in the Congenital Heart. Stephen M. Paridon, MD Medical Director, Exercise Physiology Laboratory The Children s Hospital of Philadelphia Professor of Pediatrics The University of Pennsylvania

More information

Thrombophilia and Pulmonary Endarterectomy

Thrombophilia and Pulmonary Endarterectomy Prague Medical Report / Vol. 110 (2009) No. 1, p. 51 59 51) Thrombophilia and Pulmonary Endarterectomy Lindner J. 1, Jansa P. 2, Salaj P. 3, Kunstýř J. 4, Grus T. 1, Maruna P. 5, Bláha J. 4, Rubeš D. 4,

More information

Surgical Thrombectomy for PE: Is it Making a Comeback

Surgical Thrombectomy for PE: Is it Making a Comeback Surgical Thrombectomy for PE: Is it Making a Comeback Prashanth Vallabhajosyula, MD MS The University of Pennsylvania Health System Philadelphia, PA Case - 84 year old female presents with submassive right

More information

Non-Invasive Bed-Side Assessment of Pulmonary Vascular Resistance in Critically Ill Pediatric Patients with Acute Respiratory Distress Syndrome

Non-Invasive Bed-Side Assessment of Pulmonary Vascular Resistance in Critically Ill Pediatric Patients with Acute Respiratory Distress Syndrome Aim of the Work This study aimed to evaluate the degree of pulmonary hypertension as well as alterations in the pulmonary vascular resistance in critically ill children with ARDS using bed- side echocardiography.

More information

Acid-base management during hypothermic CPB alpha-stat and ph-stat models of blood gas interpretation

Acid-base management during hypothermic CPB alpha-stat and ph-stat models of blood gas interpretation Acid-base management during hypothermic CPB alpha-stat and ph-stat models of blood gas interpretation Michael Kremke Department of Anaesthesiology and Intensive Care Aarhus University Hospital, Denmark

More information

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME

More information

Disclosures. Afterload on the PV loop. RV Afterload THE PULMONARY VASCULATURE AND ASSESSMENT OF THE RIGHT VENTRICLE

Disclosures. Afterload on the PV loop. RV Afterload THE PULMONARY VASCULATURE AND ASSESSMENT OF THE RIGHT VENTRICLE THE PULMONARY VASCULATURE AND ASSESSMENT OF THE RIGHT VENTRICLE Ryan J. Tedford, MD Heart Failure, Mechanical Circulatory Support, and Cardiac Transplantation Division of Cardiology, Department of Medicine

More information

Central extracorporeal membrane oxygenation for treatment of reperfusion oedema following pulmonary thromboendarterectomy: a case report

Central extracorporeal membrane oxygenation for treatment of reperfusion oedema following pulmonary thromboendarterectomy: a case report Edemskiy et al. Journal of Cardiothoracic Surgery (2016) 11:76 DOI 10.1186/s13019-016-0476-1 CASE REPORT Central extracorporeal membrane oxygenation for treatment of reperfusion oedema following pulmonary

More information

Untreated idiopathic pulmonary arterial hypertension

Untreated idiopathic pulmonary arterial hypertension Congenital Heart Disease Outcomes in Children With Idiopathic Pulmonary Arterial Hypertension Delphine Yung, MD; Allison C. Widlitz, MS, PA; Erika Berman Rosenzweig, MD; Diane Kerstein, MD; Greg Maislin,

More information

Right Heart Catheterization. Franz R. Eberli MD Chief of Cardiology Stadtspital Triemli, Zurich

Right Heart Catheterization. Franz R. Eberli MD Chief of Cardiology Stadtspital Triemli, Zurich Right Heart Catheterization Franz R. Eberli MD Chief of Cardiology Stadtspital Triemli, Zurich Right Heart Catheterization Pressure measurements Oxygen saturation measurements Cardiac output, Vascular

More information

THE UTILIZATION OF EXERCISE TESTS IN EVALUATING PATIENTS WITH PULMONARY VASCULAR DISEASE

THE UTILIZATION OF EXERCISE TESTS IN EVALUATING PATIENTS WITH PULMONARY VASCULAR DISEASE THE UTILIZATION OF EXERCISE TESTS IN EVALUATING PATIENTS WITH PULMONARY VASCULAR DISEASE Abdullah AlShimemeri* 1, Itani M 2, Alghadeer H 3, Al-Jahdali H 3, Al-Moamary M 3, A. Al- Duhaim A 3, Mobeireek

More information

Part I Study Questions

Part I Study Questions Part I Study Questions 1. A 59-year-old man with a history of pulmonary embolism diagnosed 2 years ago and treated with warfarin for 6 months is evaluated for progressive dyspnea and bilateral lower extremity

More information

Pulmonary hypertension in sarcoidosis

Pulmonary hypertension in sarcoidosis Pulmonary hypertension in sarcoidosis Olivier SITBON Centre de Référence de l Hypertension Pulmonaire Sévère Hôpital Universitaire de Bicêtre INSERM U999 Université Paris-Sud Le Kremlin-Bicêtre France

More information

Listing Form: Heart or Cardiovascular Impairments. Medical Provider:

Listing Form: Heart or Cardiovascular Impairments. Medical Provider: Listing Form: Heart or Cardiovascular Impairments Medical Provider: Printed Name Signature Patient Name: Patient DOB: Patient SS#: Date: Dear Provider: Please indicate whether your patient s condition

More information

M ost patients with primary pulmonary hypertension or

M ost patients with primary pulmonary hypertension or 3 CARDIOVASCULAR MEDICINE Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension N Nagaya, Y Shimizu, T Satoh, H Oya,

More information